CI Synergy American Fund

Series A USD
 

Fund overview

This fund invests primarily in equity and equity-related securities of companies which are located in countries that have signed the North American Free Trade Agreement (NAFTA) (or its successor).

Fund details

description of elementelement value
Inception date August 1992
CAD Total net assets ($CAD)
As at 2026-08-31
$119.9 million
NAVPS
As at 2026-09-16
$51.1453
MER (%)
As at 2026-03-31
2.44
Management fee (%) 2.00
Asset class U.S. Equity
Currency USD
Minimum investment $500 initial/$25 additional
Distribution frequency Annually
Last distribution $0.0870

Risk rating1

  • Low
  • Low to medium
  • Medium
  • Medium to high
  • High

FUND CODES

A ISC 545
DSC SO* 548
LL SO 1548
F 507
P 90482
*No new purchases directly into switch only funds.

Performance2 As at 2026-08-31

Growth of $10,000 (Since inception date)

growth of 10k graph

Calendar year performance

annual performance graph

average annual compound returns

YTD 1 Mo 3 Mo 6 Mo 1 Y 3 Y 5 Y 10 Y Inception*
11.22% 4.42% 5.20% 17.18% 18.00% 18.03% 9.66% 12.25% 7.44%
*Since inception date

Distribution history3

Payable date Total
2009-12-18 0.0870
2008-12-19 0.0120
1999-12-17 2.0587
1994-12-30 0.3430

Management team

First we'll display the Team Company and then the Team members
Jeremy Rosa
Aubrey Hearn

CI Synergy American Fund

Series A USD
 
Portfolio allocations4 As at 2026-08-31
Asset allocation (%)
  • US Equity 90.89
  • International Equity 6.62
  • Cash and Equivalents 2.06
  • Canadian Equity 0.47
  • Other -0.04
Sector allocation (%)
  • Technology 53.05
  • Healthcare 29.79
  • Consumer Services 8.89
  • Financial Services 5.31
  • Cash and Cash Equivalent 2.06
  • Industrial Goods 0.94
  • Other -0.04
Geographic allocation(%)
  • United States 90.81
  • Canada 2.61
  • Netherlands 2.03
  • Taiwan 1.95
  • United Kingdom 1.43
  • Cayman Islands 1.21
  • Other -0.04
Top holdings6
Sector (%)
1. NVIDIA Corp Computer Electronics 10.85%
2. Amazon.com Inc Retail 6.07%
3. Microsoft Corp Information Technology 6.03%
4. Alphabet Inc Cl C Information Technology 5.46%
5. Meta Platforms Inc Cl A Information Technology 4.36%
6. Thermo Fisher Scientific Inc Healthcare Equipment 3.71%
7. Broadcom Inc Computer Electronics 3.60%
8. Apple Inc Computer Electronics 3.13%
9. Abbott Laboratories Healthcare Equipment 3.07%
10. Eli Lilly and Co Drugs 2.88%
11. Merck & Co Inc Drugs 2.81%
12. Danaher Corp Healthcare Equipment 2.62%
13. DexCom Inc Healthcare Equipment 2.56%
14. Johnson & Johnson Drugs 2.48%
15. Gilead Sciences Inc Drugs 2.19%
Over 35,000 financial advisors have chosen CI Global Asset Management as a partner. We believe that Canadians have the best opportunity for investments success by using the services of a professional financial advisor. Learn more at ci.com.